Con­gress fires an­oth­er sal­vo at Al­ler­gan’s Mo­hawk deal; AI out­fit rais­es $60M for dis­cov­ery ef­fort

Al­ler­gan’s move to try and steer around an IPR re­view of its patents for its $1.5 bil­lion drug Resta­sis by hand­ing them over to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.